Chest, Vol 104, 1170-1175, Copyright © 1993 by American College of Chest Physicians

ARTICLES

HLA class I, II, and III polymorphism in Italian patients with sarcoidosis. The Pavia-Padova Sarcoidosis Study Group

L Pasturenzi, M Martinetti, M Cuccia, A Cipriani, G Semenzato and M Luisetti
Istituto di Tisiologia e Malattie Respiratoire, IRCCS Policlinico San Matteo, Pavia, Italy.

We studied the HLA polymorphisms (class I, II, and III) in 107 Italian patients with biopsy specimen-proven sarcoidosis in order to investigate the immunogenetic background of this disease. The mean age of onset of the disease was 36.08 +/- 12.4 years. Four patients (3.73 percent) were in radiologic stage 0, 38 patients (35.51 percent) were in radiologic stage I, 40 patients (37.38 percent) were in stage II, and 25 (23.36 percent) were in stage III. Thirty-eight patients (35.51 percent) had one or more extrapulmonary localization(s) of the disease. Positive association between sarcoidosis and HLA-B8 (chi 2 = 6.07, p = 0.0127, RR = 1.91) was confirmed. Regarding the age of onset of the disease, HLA-B35 was more frequent (chi 2 = 7.34, p = 0.0056, pc < 0.05, RR = 4.62) in patients with early onset of symptoms and/or signs, before the mean age of 36 years. With reference to the radiologic stage of the disease, HLA class II marker DR3 was more frequent in patients with stage I (chi 2 = 7.22, p = 0.0061, pc < 0.05, RR = 7.08). No significant relationship was found between sarcoidosis and HLA class III markers. These results seem to confirm an association of sarcoidosis with HLA classic genes and can sustain the hypothesis of a genetic heterogeneity of this disease.

This article has been cited by other articles:

				P. Spagnolo, E. A. Renzoni, A. U. Wells, H. Sato, J. C. Grutters, P. Sestini, A. Abdallah, E. Gramiccioni, H. J. T. Ruven, R. M. du Bois, et al. C-C Chemokine Receptor 2 and Sarcoidosis: Association with Lofgren's Syndrome Am. J. Respir. Crit. Care Med., November 15, 2003; 168(10): 1162 - 1166. [Abstract] [Full Text] [PDF]

				M. C. Iannuzzi, M. J. Maliarik, L. M. Poisson, and B. A. Rybicki Sarcoidosis Susceptibility and Resistance HLA-DQB1 Alleles in African Americans Am. J. Respir. Crit. Care Med., May 1, 2003; 167(9): 1225 - 1231. [Abstract] [Full Text] [PDF]

				H. Sato, J. C. Grutters, P. Pantelidis, A. N. Mizzon, T. Ahmad, A.-J. van Houte, J.-W. J. Lammers, J. M.M. van den Bosch, K. I. Welsh, and R. M. du Bois HLA-DQB1*0201: A Marker for Good Prognosis in British and Dutch Patients with Sarcoidosis Am. J. Respir. Cell Mol. Biol., October 1, 2002; 27(4): 406 - 412. [Abstract] [Full Text] [PDF]

				B. A. RYBICKI, M. C. IANNUZZI, M. M. FREDERICK, B. W. THOMPSON, M. D. ROSSMAN, E. A. BRESNITZ, M. L. TERRIN, D. R. MOLLER, J. BARNARD, R. P. BAUGHMAN, et al. Familial Aggregation of Sarcoidosis . A Case-Control Etiologic Study of Sarcoidosis (ACCESS) Am. J. Respir. Crit. Care Med., December 1, 2001; 164(11): 2085 - 2091. [Abstract] [Full Text] [PDF]

				J. Grunewald and A. Eklund Human leukocyte antigen genes may outweigh racial background when generating a specific immune response in sarcoidosis Eur. Respir. J., May 1, 2001; 17(5): 1046 - 1048. [Abstract] [Full Text] [PDF]

				C. M. Greene, G. Meachery, C. C. Taggart, C. P. Rooney, R. Coakley, S. J. O'Neill, and N. G. McElvaney Role of IL-18 in CD4+ T Lymphocyte Activation in Sarcoidosis J. Immunol., October 15, 2000; 165(8): 4718 - 4724. [Abstract] [Full Text] [PDF]

				G. Hunninghake Statement on Sarcoidosis Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 736 - 755. [Full Text]

				L. S. Newman, C. S. Rose, and L. A. Maier Sarcoidosis N. Engl. J. Med., April 24, 1997; 336(17): 1224 - 1234. [Full Text] [PDF]